Jounce Therapeutics, Inc. (JNCE): Price and Financial Metrics
GET POWR RATINGS... FREE!
JNCE Stock Price Chart Interactive Chart >
JNCE Price/Volume Stats
|Current price||$1.21||52-week high||$8.80|
|Prev. close||$1.19||52-week low||$0.58|
|Day high||$1.26||Avg. volume||878,673|
|50-day MA||$0.97||Dividend yield||N/A|
|200-day MA||$2.82||Market Cap||62.55M|
Jounce Therapeutics, Inc. (JNCE) Company Bio
Jounce Therapeutics, Inc. focuses on developing cancer immunotherapy treatments that enable the immune system to attack tumors. The company in 2012 and is based in Cambridge, Massachusetts.
Most Popular Stories View All
JNCE Latest News Stream
|Loading, please wait...|
JNCE Latest Social Stream
View Full JNCE Social Stream
Latest JNCE News From Around the Web
Below are the latest news stories about JOUNCE THERAPEUTICS INC that investors may wish to consider to help them evaluate JNCE as an investment opportunity.
As of Tuesday, Jounce Therapeutics Inc.’s (NASDAQ:JNCE) stock closed at $1.15, down from $1.23 the previous day. While Jounce Therapeutics Inc. has underperformed by -6.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JNCE fell by -81.89%, with highs and lows ranging from $8.80 to $0.58, […]
Jounce Therapeutics Inc. (NASDAQ:JNCE) price closed higher on Tuesday, January 10, jumping 8.41% above its previous close. A look at the daily price movement shows that the last close reads $1.07, with intraday deals fluctuated between $1.05 and $1.17. The company’s 5Y monthly beta was ticking 1.28. Taking into account the 52-week price action we … Jounce Therapeutics Inc. (NASDAQ: JNCE) Down -83.45% This Year: What Is Going To Happen Next Read More »
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Wondrous stocks: Imperial Petroleum Inc. (NASDAQ:IMPP), Jounce Therapeutics, Inc. (NASDAQ:JNCE) appeared first on Stocks Equity .
In last trading session, Jounce Therapeutics Inc. (NASDAQ:JNCE) saw 1.9 million shares changing hands with its beta currently measuring 0.89. Company’s recent per share price level of $1.16 trading at -$0.06 or -4.92% at ring of the bell on the day assigns it a market valuation of $60.51M. That closing price of JNCE’s stock is … Jounce Therapeutics Inc. (NASDAQ:JNCE) Falls -4.92%, But An Additional Plunge May Follow. Read More »
Jounce Therapeutics, Inc. (NASDAQ:JNCE) with the stream of -1.80% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of 48.51% in the last hour of Tuesday’s trading session. Jounce … The post Stock is blowing up: Jounce Therapeutics, Inc. (NASDAQ:JNCE), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .
JNCE Price Returns
Continue Researching JNCEWant to see what other sources are saying about Jounce Therapeutics Inc's financials and stock price? Try the links below:
Jounce Therapeutics Inc (JNCE) Stock Price | Nasdaq
Jounce Therapeutics Inc (JNCE) Stock Quote, History and News - Yahoo Finance
Jounce Therapeutics Inc (JNCE) Stock Price and Basic Information | MarketWatch